ArticleBlood advances2025

Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models.

Sankaranarayanan Kannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.